Page last updated: 2024-08-21

durapatite and Coronary Artery Disease

durapatite has been researched along with Coronary Artery Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Bellasi, A; Bover, J; Bushinsky, D; Chertow, GM; Garg, R; Gillotti, K; Gold, A; Ketteler, M; Padgett, C; Perelló, J; Raggi, P; Rodriguez, M; Salcedo, C; Sinha, S1
Adamson, PD; Alcaide-Corral, CJ; Andrews, JPM; BouHaidar, R; Doris, MK; Dweck, MR; Leipsic, JA; MacRae, VE; Moss, AJ; Newby, DE; Seidman, MA; Sellers, SL; Shah, ASV; Sim, AM; Tavares, AAS; Williams, MC1
Hiruta, N; Kobayashi, T; Nakagawa, O; Shimoyama, E; Shirai, S; Uchida, Y1
Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Mattos, LA; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF1
Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Maldonado, G; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF1
Carr, JJ; Detrano, R; Goldin, JG; Kronmal, RA; Loria, CM; McNitt-Gray, MF; Nelson, JC; Williams, OD; Wong, ND1
Detrano, R; Garner, D; Gutfinger, D; Kang, X; Mahaisavariya, P; McCrae, M; Measham, C; Molloi, S; Peng, SK; Tang, W1
Colombo, A; Detrano, R; Garner, D; Kang, X; Mahaisavariya, P; Molloi, S; Nickerson, S; Tang, W1

Trials

1 trial(s) available for durapatite and Coronary Artery Disease

ArticleYear
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
    Circulation, 2020, 03-03, Volume: 141, Issue:9

    Topics: Aged; Aortic Valve; Coronary Artery Disease; Disease Progression; Double-Blind Method; Durapatite; Europe; Female; Heart Valve Diseases; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vascular Calcification

2020

Other Studies

7 other study(ies) available for durapatite and Coronary Artery Disease

ArticleYear
Ex vivo
    Scientific reports, 2020, 11-19, Volume: 10, Issue:1

    Topics: Adult; Aged; Cadaver; Core Binding Factor Alpha 1 Subunit; Coronary Artery Disease; Durapatite; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Organ Culture Techniques; Osteogenesis; Osteopontin; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Spectrum Analysis, Raman; X-Ray Microtomography

2020
Fluorescent angioscopic imaging of calcium phosphate tribasic: precursor of hydroxyapatite, the major calcium deposit in human coronary plaques.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:10

    Topics: Aged; Angioscopy; Autopsy; Azo Compounds; Biomarkers; Calcium Phosphates; Collagen Type I; Coronary Artery Disease; Coronary Vessels; Durapatite; Female; Fluorescent Dyes; Humans; Luminescent Measurements; Male; Middle Aged; Necrosis; Optical Imaging; Plaque, Atherosclerotic; Predictive Value of Tests; Vascular Calcification

2017
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Durapatite; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prosthesis Design; Registries; Sirolimus; Stainless Steel; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2008
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial.
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Durapatite; Female; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Sirolimus; Ticlopidine; Time Factors; Ultrasonography

2009
Measuring coronary calcium on CT images adjusted for attenuation differences.
    Radiology, 2005, Volume: 235, Issue:2

    Topics: Algorithms; Body Mass Index; Calcinosis; Calibration; Coronary Artery Disease; Data Interpretation, Statistical; Durapatite; Female; Humans; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Phantoms, Imaging; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Tomography, Spiral Computed; Tomography, X-Ray Computed

2005
Accurate coronary calcium phosphate mass measurements from electron beam computed tomograms.
    American journal of cardiac imaging, 1995, Volume: 9, Issue:3

    Topics: Algorithms; Calcium; Calcium Phosphates; Chemical Precipitation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Durapatite; Electrons; Humans; Image Processing, Computer-Assisted; Models, Structural; Regression Analysis; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed

1995
Accuracy of quantifying coronary hydroxyapatite with electron beam tomography.
    Investigative radiology, 1994, Volume: 29, Issue:8

    Topics: Algorithms; Calibration; Coronary Artery Disease; Coronary Vessels; Durapatite; Humans; Models, Cardiovascular; Models, Structural; Particle Size; Predictive Value of Tests; Subtraction Technique; Tomography, X-Ray Computed

1994